Evidence map›Paper›PMID 35818072›Full record

ArticleHarm reduction journal2022

"It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.

Sarah S Shin, Kate LaForge, Erin Stack, Justine Pope, Gillian Leichtling, Jessica E Larsen, Judith M Leahy, Andrew Seaman, Daniel Hoover, Laura Chisholm and 5 more

Open access · goldAbstract read
In one paragraph

Article in Harm reduction journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Sarah S ShinComagine Health, 650 NE Holladay Street #1700, Portland, OR, 97232, USA. sshin@comagine.org.
Kate LaForgeComagine Health, 650 NE Holladay Street #1700, Portland, OR, 97232, USA.
Erin StackComagine Health, 650 NE Holladay Street #1700, Portland, OR, 97232, USA.
Justine PopeComagine Health, 650 NE Holladay Street #1700, Portland, OR, 97232, USA.
Gillian LeichtlingComagine Health, 650 NE Holladay Street #1700, Portland, OR, 97232, USA.
Jessica E LarsenDepartment of Medicine, Section of Addiction Medicine, Oregon Health and Science University, Portland, OR, USA.
Judith M LeahyAcute and Communicable Disease Prevention, Public Health Division, Oregon Health Authority, Portland, OR, USA.
Andrew SeamanDepartment of Medicine, Section of Addiction Medicine, Oregon Health and Science University, Portland, OR, USA.
Daniel HooverDepartment of Medicine, Section of Addiction Medicine, Oregon Health and Science University, Portland, OR, USA.
Laura ChisholmInjury and Violence Prevention Program, Public Health Division, Oregon Health Authority, Portland, OR, USA.
Christopher BlazesDepartment of Medicine, Section of Addiction Medicine, Oregon Health and Science University, Portland, OR, USA.
Robin BakerSchool of Public Health, Oregon Health and Science University-Portland State University, Portland, OR, USA.
Mikaela ByersHIV Alliance, Eugene, OR, USA.
Katie BransonInjury and Violence Prevention Program, Public Health Division, Oregon Health Authority, Portland, OR, USA.
P Todd KorthuisDepartment of Medicine, Section of Addiction Medicine, Oregon Health and Science University, Portland, OR, USA.
Oregon Health Authority · USOregon Health & Science University · USPortland State University · USCentral City Concern · US

Funding

Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study Cost ExtensionUH3DA044831 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KORTHUIS, PHILIP TODD · 2019 to 2022
$4.0M
NIDA NIH HHS UG1DA01581NIDA NIH HHS UH3 DA044831
6 · The paper itself

Abstract

backgroundIllicit fentanyl has contributed to a drastic increase in overdose drug deaths. While fentanyl has subsumed the drug supply in the Northeastern and Midwestern USA, it has more recently reached the Western USA. For this study, we explored perspectives of people who use drugs (PWUD) on the changing drug supply in Oregon, experiences of and response to fentanyl-involved overdose, and recommendations from PWUD to reduce overdose risk within the context of illicit fentanyl's dramatic increase in the recreational drug supply over the past decade.

methodsWe conducted in-depth interviews by phone with 34 PWUD in Oregon from May to June of 2021. We used thematic analysis to analyze transcripts and construct themes.

resultsPWUD knew about fentanyl, expressed concern about fentanyl pills, and were aware of other illicit drugs containing fentanyl. Participants were aware of the increased risk of an overdose but remained reluctant to engage with professional first responders due to fear of arrest. Participants had recommendations for reducing fentanyl overdose risk, including increasing access to information, harm reduction supplies (e.g., naloxone, fentanyl test strips), and medications for opioid use disorder; establishing drug checking services and overdose prevention sites; legalizing and regulating the drug supply; and reducing stigma enacted by healthcare providers.

conclusionPWUD in Oregon are aware of the rise of fentanyl and fentanyl pills and desire access to tools to reduce harm from fentanyl. As states in the Western USA face an inflection point of fentanyl in the drug supply, public health staff, behavioral health providers, and first responders can take action identified by the needs of PWUD.

Indexed as

Drug OverdoseFentanylIllicit DrugsOpiate OverdoseOpioid-Related DisordersAnalgesics, OpioidHumansOregonAnalgesics, OpioidFentanylIllicit DrugsDrug supplyEMSFentanylLaw enforcementOpioidsOverdosePeople who use drugsQualitativeSubstance use

Identifiers

PMID35818072
PMCPMC9275036
OpenAlexW4285042560

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.